Press Release
Back |
Anthem Announces Research Study with Apple Watch to Help Improve Asthma Management |
The study, to be led by the This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200916005283/en/ ![]()
Launching in the fall, the two-year, randomized controlled study will enroll participants from
“As part of our mission of improving people’s lives, we are making it easier for consumers to proactively manage their health through our digital-first approach to delivering healthcare solutions and services,” said The primary goal of the study is to investigate clinical changes in outcomes associated with the use of the new digital tools in self-management of asthma. Additionally, the study will explore if data collected from everyday use devices such as iPhone and Apple Watch can help predict asthma exacerbation or serve as potential digital biomarkers of asthma control.
“Personalized medicine and improving the health of populations are based on similar principles. The human body contains critical information – data – necessary to diagnose and treat our patients,” said Dr.
“The Digital Asthma Study brings together Apple Watch’s innovative technology with an engaging app-based self-management experience to investigate how consumers can better manage and control a prevalent condition,” says About the Study Eligible participants will be invited to enroll in the study. Participants who choose to enroll in the study will receive a BedditTM Sleep Monitor and an Apple Watch. While there is no cure for asthma, studies have shown that many people can improve their symptoms and reduce exacerbation risk through self-management behaviors including avoiding triggers - such as pollen, mold or smoke - medication adherence, and correct inhaler technique.1 However, asthma self-management is often far from ideal, with some data suggesting that less than 50 percent of individuals with asthma are well-controlled.2 Scalable and effective solutions are needed to empower patients to improve asthma self-management and reduce the need for costly asthma care.3 To investigate the impact of digital intervention on asthma symptoms and healthcare utilization, the active group of the study will have access to the digital asthma tool, designed for the study. The digital asthma tool includes daily symptom and trigger tracking to provide awareness of asthma control and personalized nudges based on changes in signals from their Apple Watch including activity, heart rate, the new Blood Oxygen feature and other health metrics. Participants will also receive timely curated education materials and prescription refill resources. Designed with patient privacy in mind, the study offers the participants complete control over their data, and transparency into how the data will be used and shared. Data will be stored on the participants’ device and shared through a direct, encrypted connection with CareEvolution.
About
About the
Founded in 1965, UCI is the youngest member of the prestigious
1https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487370/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005283/en/
Media Contacts:
Source: |